About
Dr. Chua is a Clinician-Scientist, who is supported by the NMRC Clinician-Scientist Award. His research focuses on the development of Ph II-III clinical trials in nasopharyngeal (NPC) and prostate cancers. He also runs a laboratory that is involved in data science and omics analytics that help with therapeutic and biomarker discovery for these cancer types.
Other Appointments
- Principal Investigator, Tan Chin Tuan Laboratory of Optical Imaging, Photodynamic and Proton Therapy – Precision Radiation Oncology Programme, National Cancer Centre Singapore
- Director, Data and Computational Science Core, National Cancer Centre Singapore
- Associate Professor (Tenured), Duke-NUS Medical School, Singapore
- Visiting Professor, Zhongnan Hospital of Wuhan University, China
Key Accomplishments
- ASCO-CSCO International guidelines on the treatment of locoregionally-advanced NPC, which was published in the Journal of Clinical Oncology
- Co-Lead investigator of the randomised controlled trial of induction gemcitabine-cisplatin in high-risk locoregionally-advanced NPC, which defined the new standard-of-care (research was published in the New England Journal of Medicine)
- Co-Lead investigator of the randomised controlled trial of consolidation radiotherapy in patients with metastatic NPC who manifest a good response to palliative chemotherapy. This study again defined a new standard-of-care in these patients (published in JAMA Oncology)
- Developed a web-based, free-to-use tool to stratify patients with locoregionally recurrent NPC for re-irradiation (PRANCIS: Prediction of RAdioresistant Nasopharyngeal CarcInoma Survival; ww.PRANCIS.Medlever.com). This is impactful, given that 50% of death events in this patient subgroup are due to re-treatment toxicities (published in the Journal of Clinical Oncology)
Education / Honors
- NMRC Clinician-Scientist Award (Investigator), 2015, 2018, 2021
- Fellow of the Academy of Medicine Singapore (FAMS), The College of Radiation Oncology and Clinician Scientists, Singapore, 2021
- Conquer Cancer Foundation ASCO Merit Award, 2017, 2016, 2013
- Doctor of Philosophy (PhD), University College London, UK, 2013
- Fellow of the Royal College of Radiologists (FRCR for Clinical Oncology), The Royal College of Radiologists, UK, 2013
Please Leave a Review or Suggestion